David Colleran, EVP, General Counsel, Corporate Secretary at Anika Therapeutics, Inc. (ANIK), bought 1,500 shares at $21.37 ($32K) on 2022-05-11, disclosed to the SEC on 2022-05-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| PODD | SELL | 2019-03-05 | $4.0M | — | Filing → |
| PODD | SELL | 2019-02-06 | $1.1M | — | Filing → |
| PODD | SELL | 2019-02-01 | $386K | — | Filing → |